Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul-Aug;91(4):472-8.
doi: 10.1590/abd1806-4841.20164412.

Skin barrier in atopic dermatitis: beyond filaggrin

Affiliations
Review

Skin barrier in atopic dermatitis: beyond filaggrin

Mariana Colombini Zaniboni et al. An Bras Dermatol. 2016 Jul-Aug.

Abstract

Atopic dermatitis is a chronic inflammatory skin disease with a complex pathogenesis, where changes in skin barrier and imbalance of the immune system are relevant factors. The skin forms a mechanic and immune barrier, regulating water loss from the internal to the external environment, and protecting the individual from external aggressions, such as microorganisms, ultraviolet radiation and physical trauma. Main components of the skin barrier are located in the outer layers of the epidermis (such as filaggrin), the proteins that form the tight junction (TJ) and components of the innate immune system. Recent data involving skin barrier reveal new information regarding its structure and its role in the mechanic-immunological defense; atopic dermatitis (AD) is an example of a disease related to dysfunctions associated with this complex.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Expression of filaggrin (FLG), claudin 1 (CLDN1) and claudin 4 (CLDN4) in skin fragments of adults with atopic dermatitis (AD) stained by immunohistochemistry. (A) Skin fragments of healthy controls: FLG, CLDN1 and CLDN4. (B) Skin fragments of patients with AD, showing reduced expression of FLG, CLDN1 and CLDN4. (C) Expression of FLG, CLDN1 and CLDN 4 (area percentage) in the control group without AD (n=33) compared with patients with AD (n=25). (D) Correlation between disease severity (EASI) and the expression of the proteins in the skin barrier. The line represents the arithmetic mean of the expression of proteins in the skin barrier (percentage area). ** p≤0.01 and *** p≤0.001
Figure 2
Figure 2
Main components of innate immune system in epidermis and their role in atopic dermatitis (AD). Defects in Toll-like receptor 2 contribute to increased colonization and infection by S. aureus. Decreased AD expression of AMP (catelicidin-LL37 and β-defensin) also favors skin infections. Reduced plasmacytoid dendritic cells in skin injured areas by AD, facilitating certain viral skin infections. Reduced NK cells in AD. S. epidermidis increase the expression of human β-defensin by human keratinocytes through TLR2 signaling pathway. IDEC are increased in AD skin lesion. NOD1 changes are associated with elevated IgE levels in AD individuals. Changes in expression of NLRP1 gene were associated to AD severity formula image Staphylococcus aureus (S. aureus), formula image Staphylococcus epidermidis (S. epidermidis), formula image other bacteria, formula image staphylococcal enterotox in, formula image virus, formula image Toll-like receptors (TLR), formula image nucleotide-binding oligomerization domain-containing protein (NOD) formula image NOD-like receptor protein (NLRP) formula image β-defensina 1, formula image HBD-2,3 e LL37, formula image inflammatory dendritic epidermal cells (IDEC), formula image plasmacytoid DC (pDC).

Similar articles

Cited by

References

    1. Kapoor R, Menon C, Hoffstad O, Bilker W, Leclerc P, Margolis DJ. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol. 2008;58:68–73. - PubMed
    1. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, Group IPTS Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124:1251–1258. e23. - PubMed
    1. Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol. 2008;121:1337–1343. - PMC - PubMed
    1. Agrawal R, Woodfolk JA. Skin barrier defects in atopic dermatitis. Curr Allergy Asthma Rep. 2014;14:433–433. - PMC - PubMed
    1. Addor FA, Aoki V. Skin barrier in atopic dermatitis. An Bras Dermatol. 2010;85:184–194. - PubMed

MeSH terms

Substances